Geneos Wealth Management’s ViewRay, Inc. VRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,215
Closed -$36.8K 2125
2022
Q4
$36.8K Sell
8,215
-8,206
-50% -$35.7K ﹤0.01% 1156
2022
Q3
$59K Sell
16,421
-18,308
-53% -$61.4K ﹤0.01% 980
2022
Q2
$92K Buy
34,729
+5,522
+19% +$16.6K ﹤0.01% 1037
2022
Q1
$114K Buy
29,207
+15,824
+118% +$67.4K ﹤0.01% 1040
2021
Q4
$73K Sell
13,383
-2,054
-13% -$12.5K ﹤0.01% 1307
2021
Q3
$107K Sell
15,437
-7,706
-33% -$48.7K ﹤0.01% 1154
2021
Q2
$151K Hold
23,143
0.01% 979
2021
Q1
$111K Hold
23,143
﹤0.01% 1259
2020
Q4
$106K Buy
+23,143
New +$81.8K ﹤0.01% 1126

Other funds holding VRAY

Geneos Wealth Management's VRAY Position: Q1 2023 in Review

Geneos Wealth Management sold out of ViewRay, Inc. (VRAY) in Q1 2023, closing a stake of 8,215 shares — an estimated $36.8K sold.

Geneos Wealth Management first reported a position in VRAY in Q4 2020 and held it in 9 quarters. The position peaked at $151K in Q2 2021. 171 funds tracked by Wall St. Rank hold VRAY as of Q1 2023.

  • Geneos Wealth Management reported no remaining ViewRay, Inc. position as of Q1 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 8,215 ViewRay, Inc. shares in Q1 2023, an estimated $36.8K.
  • Geneos Wealth Management first reported a position in ViewRay, Inc. in Q4 2020 and held it in 9 quarters.
  • Geneos Wealth Management's ViewRay, Inc. position peaked at $151K in Q2 2021.
  • 171 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q1 2023.

Based on Geneos Wealth Management's 13F filing for Q1 2023, filed 25 Apr 2023.